Top Markets
#1 Helium Helium +52.91%
#2 TENDIES TENDIES +38.83%
#3 Seeker Seeker +17.09%
#4 Pons Pons +16.78%
#5 Songbird Songbird +12.59%
#6 UnifAI Network UnifAI Network +12.30%
#7 Biconomy Biconomy +10.16%
#8 OSK OSK +9.90%
#9 MarsCoin MarsCoin +9.01%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +8.67%
Coin of the day
Helium Helium
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Shanghai Kaibao Pharmaceutical CO.,Ltd Shanghai Kaibao Pharmaceutical CO.,Ltd

Shanghai Kaibao Pharmaceutical CO.,Ltd

300039
Classement en actions #10244
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research,... Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
Prix de l'action
$0.82890742
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$867.04M
Changement (1 jour)
-4.19%
Changement (1 an)
-5.58%
Pays
CN
Échange Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)

Catégorie

Healthcare
Ratio P/B pour Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Shanghai Kaibao Pharmaceutical CO.,Ltd, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Shanghai Kaibao Pharmaceutical CO.,Ltd de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.5207 -
IN